ClinicalTrials.Veeva

Menu
S

Southwest Retina Research Center | Durango, CO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

APL-2
GT005
Iptacopan
Ranibizumab
MK-8748
Pegcetacoplan
EYE201

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 11 total trials
Locations recently updated

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) (TORRONTES)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling
Choroidal Neovascularization
Age-Related Macular Degeneration
Drug: Tiespectus
Drug: Aflibercept

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atroph...

Enrolling
Age-related Macular Degeneration (AMD)
Geographic Atrophy (GA)
Drug: Placebo
Drug: Pozelimab

The purpose of this study is to evaluate the long-term safety of GT005 in participants with Geographic Atrophy (GA) secondary to AMD who have been tr...

Invitation-only
Age Related Macular Degeneration (AMD)
Genetic: GT005

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Active, not recruiting
Choroidal Neovascularization
Wet Age-related Macular Degeneration
Genetic: ABBV-RGX-314
Biological: Ranibizumab (LUCENTIS®)

ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of ne...

Active, not recruiting
Wet Age-related Macular Degeneration
WetAMD
Genetic: ABBV-RGX-314 Dose 1
Biological: Aflibercept (EYLEA®)

Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of th...

Enrolling
Diabetic Retinopathy
Drug: Topical Steroid
Drug: Artificial Tears

Trial sponsors

AbbVie logo
A
G
E
Novartis logo
Regeneron Pharmaceuticals logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems